| Name | Title | Contact Details |
|---|
New! Solitaire by MobilityWare is now available to play online for free! No registration or download needed. Play directly on our website from your computer, phone or tablet. Enjoy Winning Deals, Daily Challenges, Stat Tracking and more!
CareAcademy provides high-quality, state-approved online caregiver training for home care agencies that increases caregiver knowledge.
Disrupted retail, new channels, sustainability initiatives, emerging markets, upstart brands and ever-changing consumer preferences combine to create a new era of complexity in the $1 Trillion consumer goods market. The challenges are relentless, but businesses that overcome them will be rewarded with accelerated innovation, less wasteful supply chains, reimagined portfolios and increased market share. All in a cost-constrained environment. To win in this new era, agility becomes your competitive differentiator. Nulogy unleashes business agility fueled by a high-performing external supply chain of contract manufacturers and packaging suppliers. This multi-enterprise ecosystem must be collaborative, connected, responsive, and innovation-centric. Deployed by industry leaders on five continents, in hundreds of sites, in multiple languages, and across a broad range of CPG and FMCG industries, Nulogy has been named by Gartner as the only solution provider bridging the gap between CPGs and their networks of contract manufacturing and packaging suppliers. That`s why the world`s leading brands including L`Oréal, P&G, Mars, and Church & Dwight leverage Nulogy to optimize and accelerate global supply chain performance. And, the world`s leading 3PLs, contract packagers and contract manufacturers also rely on Nulogy to ensure they can deliver the visibility, responsiveness, and accelerated innovation that their CPG customers value.
Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality.
Harnessing the power of the regulatory genome to create highly selective, next-generation molecular therapies